1000 mcg bpc 157 BPC-157+TB-500 Blend Caps 1000mcg | HPLC + COA BPC-157 Capsules 1000mcg — 90ct

Discontinuation Rates Discontinuation rates due to adverse events in the Phase 2 trial were dose-dependent, ranging from approximately 6% in the 1 mg arm to 16% in the 12 mg arm

Evidence includes: Stimulation of endothelial and keratinocyte migration Enhanced blood vessel density in wound healing models Promotion of stem cell differentiation toward repair cell lineages Low molecular weight enabling tissue penetration over long distances Unlike growth factors that bind to extracellular matrix, TB-500s mobility allows systemic distribution to multiple injury sites

BPC-157 consists of a short chain of amino acids, which places it in the peptide category from a biochemical standpoint

Professional B12 injections tend to be more expensive due to clinical visits and possible consultation fees